Erlotinib
Active substance: erlotinib
TABLET, FILM COATED · ERLOTINIB HYDROCHLORIDE 100 mg/1
United StatesActive
Marketing holder: Teva Pharmaceuticals USA, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ERLOTINIB HYDROCHLORIDE · 100 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-626f-76f7-8600-fb09a3a48015,01a1208c-a68f-7cd0-b6af-f37da7ef915d,01a1208d-0122-77e8-bd41-1d23da3e09ab,01a1208d-05a4-7d1b-9fb9-511eeb14e392,01a1208d-66bc-7acb-8c25-0e9036be72db;count=30 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0093-7663
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0093-7663 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0093-7663 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0093-7663 · Verified 2026-10-09 · open in source